SEC Form 4 · Insider disclosures

Insider Trading Tracker

Who bought, who sold, and the disclosed plans and ownership context behind recent SEC Form 4 filings.

Updates are delayed; the last verified disclosures remain available.

Purchase rows312
Sale rows1,613
Purchase value (USD)US$469.72M
Sale value (USD)US$1.44B

Last 10 days of filings·Updated Oct 23, 3:53 AM ET

Recent company disclosures

1 companies · 1 rows
ORIC

Oric Pharmaceuticals, Inc.

Total value ≈ US$189.39K

1 transaction rows · 1 filings

Piscitelli Dominic

Sale
CFO disclosed sale of 14,000 shares

Filing includes a 10b5-1 plan; attribution to this row is unconfirmed

Approximately 69.8K shares in direct holdings afterward; change percentage not reliably calculable

Calculated transaction value approximately US$189.39K
Sources, coverage & updates
SEC filing dates: 2026-10-14 — 2026-10-23 (America/New_York)

Current-day data is provisional; historical dates are reconciled to official daily indexes.

Last successful sync: Oct 23, 3:53 AM ET

Historical dates reconciled; current day provisional

Discovered filings 2,284 · Parsed 2,284 · Pending 0

Table I non-derivative P/S only. Values use reported price × shares; 9 unavailable, unverified or non-USD amounts are excluded. 743 filings · 691 distinct reporting owners, not necessarily independent decision-makers.

Company grouping is a reading aid, not a merger of transactions or uncertain ownership ratios. Value sorting uses each company’s usable total; expand to see every matching row.

Reading these disclosures

Form 4 disclosures are not real-time trade alerts. An unchecked 10b5-1 indicator does not establish discretionary timing. Direct and indirect holdings remain separate; unresolved amendments stay under review.

Filed prices are not all independently market-verified. Source: SEC EDGAR; the update target is every 15 minutes. Actual freshness is shown by the last successful synchronization.

SEC transaction codes ↗